Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
Solara's revenue at Rs 394 crore returned to its historical quarterly run-rate and also more than tripled from the year-ago period.
Solara delivered a profit of Rs 45 lakh during the September quarter, compared to a net loss of Rs 139.87 crore during the same period last year.
The company's revenue at Rs 394 crore returned to its historical quarterly run-rate and also more than tripled from the year-ago period.
Solara also delivered an operating profit for the quarter of Rs 45 crore, compared to an EBITDA loss of nearly Rs 100 crore last year. EBITDA margin for the quarter stood at 11.4 percent.
The company's management called this a "turnaround quarter" where it achieved most of its targeted goals. The management further said that their order book continues to improve each quarter and that cost improvement plans are starting to deliver the desired outcomes, aiding profitability.
Solara Active Pharma’s site in Vizag, Andhra Pradesh, began manufacturing intermediates and final API in the December quarter, while the company’s research and development segment filed two new DMFs (drug master files) during the quarter, on track to file a total of six in the current financial year.
Solara has also appointed Poorvank Purohit as the new CEO.
Shares of Solara ended 4.4 percent higher at Rs 436.15.
(Edited by : Rukmani Krishna)
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!